高钠血症
医学
肾功能
急性肾损伤
肌酐
肾病科
肾脏替代疗法
重症监护医学
内科学
Copeptin蛋白
钠
加压素
化学
有机化学
作者
Marjolein van IJzendoorn,Linda de Vries,Jacob van den Born,Hanneke Buter,Gerjan Navis,E. Christiaan Boerma
出处
期刊:Journal of Translational Internal Medicine
[De Gruyter]
日期:2020-09-01
卷期号:8 (3): 165-176
被引量:9
标识
DOI:10.2478/jtim-2020-0026
摘要
The development of ICU-acquired hypernatremia (IAH) is almost exclusively attributed to 'too much salt and too little water'. However, intrinsic mechanisms also have been suggested to play a role. To identify the determinants of IAH, we designed a prospective controlled study.Patients with an anticipated length of stay ICU > 48 hours were included. Patients with hypernatremia on admission and/or on renal replacement therapy were excluded. Patients without IAH were compared with patients with borderline hypernatremia (≥ 143 mmol/L, IAH 143) and more severe hypernatremia (≥ 145 mmol/L, IAH 145).We included 89 patients, of which 51% developed IAH 143 and 29% IAH 145. Sodium intake was high in all patients. Fluid balances were slightly positive and comparable between the groups. Patients with IAH 145 were more severely ill on admission, and during admission, their sodium intake, cumulative sodium balances, serum creatinine and copeptin levels were higher. According to the free water clearance, all the patients conserved water. On multivariate analysis, the baseline serum creatinine was an independent risk factor for the development of IAH 143 and IAH 145. Also, the copeptin levels remained significant for IAH 143 and IAH 145. Sodium intake remained only significant for patients with IAH 145.Our data support the hypothesis that IAH is due to the combination of higher sodium intake and a urinary concentration deficit, as a manifestation of the renal impairment elicited by severe illness.
科研通智能强力驱动
Strongly Powered by AbleSci AI